Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
C-Rad AB Class B ( ($SE:CRAD.B) ) has provided an announcement.
C-RAD AB announced that it will publish its year-end report and fourth-quarter 2025 results on Thursday, 12 February 2026 at 08:00 CET, followed by an English-language presentation at 11:00 CET led by CEO Tomas Blomquist and CFO Linda Frölén. Investors and analysts can participate via webcast or teleconference, with opportunities to ask questions, and a recording of the event will later be made available on the company’s website, underscoring C-RAD’s efforts to maintain transparent communication with capital markets as it advances its position in the radiation therapy technology sector.
The most recent analyst rating on ($SE:CRAD.B) stock is a Hold with a SEK35.00 price target. To see the full list of analyst forecasts on C-Rad AB Class B stock, see the SE:CRAD.B Stock Forecast page.
More about C-Rad AB Class B
C-RAD AB is a medical technology company specializing in surface-guided imaging solutions for radiation therapy, designed to deliver highly accurate radiation doses to tumors while minimizing exposure to healthy tissue. Using high-speed 3D cameras and augmented reality, its systems support patient setup and real-time motion monitoring without tattoos or additional imaging dose, enhancing safety, comfort and workflow efficiency. The company is listed on Nasdaq Stockholm and targets the global radiotherapy market.
Average Trading Volume: 37,186
Technical Sentiment Signal: Sell
Current Market Cap: SEK1.09B
See more insights into CRAD.B stock on TipRanks’ Stock Analysis page.